Hayashi Y et al. |
Torsades de pointes ventricular tachycardia induced by clarithromycin and disopyramide in the presence of hypokalemia. |
1999 |
Pacing Clin Electrophysiol |
pmid:10234723
|
Pilotto A et al. |
The effect of antibiotic resistance on the outcome of three 1-week triple therapies against Helicobacter pylori. |
1999 |
Aliment. Pharmacol. Ther. |
pmid:10233191
|
Goddard AF et al. |
Randomized controlled comparison of nitroimidazoles for the eradication of Helicobacter pylori and relief of ulcer-associated and non-ulcer dyspepsia. |
1999 |
Aliment. Pharmacol. Ther. |
pmid:10233187
|
Gisbert JP |
[Lansoprazole: a review of its role in Helicobacter pylori eradication therapy]. |
1999 |
Rev Esp Enferm Dig |
pmid:10231305
|
Gisbert JP et al. |
[Antral biopsy is sufficient to confirm Helicobacter pylori eradication with the "new" one-week long triple treatments]. |
1999 |
Med Clin (Barc) |
pmid:10227015
|
Bergman KL et al. |
Antimicrobial activities and postantibiotic effects of clarithromycin, 14-hydroxy-clarithromycin, and azithromycin in epithelial cell lining fluid against clinical isolates of haemophilus influenzae and Streptococcus pneumoniae. |
1999 |
Antimicrob. Agents Chemother. |
pmid:10223956
|
Fish DN and Abraham E |
Pharmacokinetics of a clarithromycin suspension administered via nasogastric tube to seriously ill patients. |
1999 |
Antimicrob. Agents Chemother. |
pmid:10223952
|
Garey KW et al. |
Lack of effect of zafirlukast on the pharmacokinetics of azithromycin, clarithromycin, and 14-hydroxyclarithromycin in healthy volunteers. |
1999 |
Antimicrob. Agents Chemother. |
pmid:10223928
|
Sato K and Tomioka H |
Antimicrobial activities of benzoxazinorifamycin (KRM-1648) and clarithromycin against Mycobacterium avium-intracellulare complex within murine peritoneal macrophages, human macrophage-like cells and human alveolar epithelial cells. |
1999 |
J. Antimicrob. Chemother. |
pmid:10223590
|
Khan AA et al. |
Effect of clarithromycin and azithromycin on production of cytokines by human monocytes. |
1999 |
Int. J. Antimicrob. Agents |
pmid:10221415
|
van der Hulst RW et al. |
[Treatment of Helicobacter pylori infections]. |
1999 |
Ned Tijdschr Geneeskd |
pmid:10221109
|
Abbott GW et al. |
MiRP1 forms IKr potassium channels with HERG and is associated with cardiac arrhythmia. |
1999 |
Cell |
pmid:10219239
|
Hoffman JS et al. |
Efficacy of a 1-week regimen of ranitidine bismuth citrate in combination with metronidazole and clarithromycin for Helicobacter pylori eradication. |
1999 |
Aliment. Pharmacol. Ther. |
pmid:10215735
|
Neville PM et al. |
The optimal antibiotic combination in a 5-day Helicobacter pylori eradication regimen. |
1999 |
Aliment. Pharmacol. Ther. |
pmid:10215734
|
Lee JM et al. |
Treatment options for Helicobacter pylori infection when proton pump inhibitor-based triple therapy fails in clinical practice. |
1999 |
Aliment. Pharmacol. Ther. |
pmid:10215733
|
Kashimura H et al. |
Polaprezinc, a mucosal protective agent, in combination with lansoprazole, amoxycillin and clarithromycin increases the cure rate of Helicobacter pylori infection. |
1999 |
Aliment. Pharmacol. Ther. |
pmid:10215732
|
Clifford K et al. |
Double-blind comparative trial of ciprofloxacin versus clarithromycin in the treatment of acute bacterial sinusitis. Sinusitis Infection Study Group. |
1999 |
Ann. Otol. Rhinol. Laryngol. |
pmid:10214783
|
Dubois J and St-Pierre C |
In vitro activity of gatifloxacin, compared with ciprofloxacin, clarithromycin, erythromycin, and rifampin, against Legionella species. |
1999 |
Diagn. Microbiol. Infect. Dis. |
pmid:10212753
|
McConnell SA and Amsden GW |
Review and comparison of advanced-generation macrolides clarithromycin and dirithromycin. |
1999 |
Pharmacotherapy |
pmid:10212011
|
Henry DC et al. |
Comparison of sparfloxacin and clarithromycin in the treatment of acute bacterial maxillary sinusitis. Sparfloxacin Multicenter AMS Study Group. |
1999 |
Clin Ther |
pmid:10211537
|
Miwa H et al. |
Efficacy of 1 week omeprazole or lansoprazole-amoxycillin-clarithromycin therapy for Helicobacter pylori infection in the Japanese population. |
1999 |
J. Gastroenterol. Hepatol. |
pmid:10207779
|
Zhou Q et al. |
CYP2C19 genotypes and omeprazole metabolism after single and repeated dosing when combined with clarithromycin. |
1999 |
Eur. J. Clin. Pharmacol. |
pmid:10206083
|
Laine L et al. |
Once-daily therapy for H. pylori infection: a randomized comparison of four regimens. |
1999 |
Am. J. Gastroenterol. |
pmid:10201465
|
Smoot DT et al. |
Effectiveness of ranitidine bismuth citrate, clarithromycin, and metronidazole therapy for treating Helicobacter pylori. |
1999 |
Am. J. Gastroenterol. |
pmid:10201463
|
Sonnenberg A et al. |
The effect of antibiotic therapy on bleeding from duodenal ulcer. |
1999 |
Am. J. Gastroenterol. |
pmid:10201462
|
Verbanck JJ et al. |
Campylobacter jejuni II peritonitis in a CCPD patient: cure by oral clarithromycin. |
1999 Jan-Feb |
Perit Dial Int |
pmid:10201350
|
Lee CK et al. |
Immunization with recombinant Helicobacter pylori urease decreases colonization levels following experimental infection of rhesus monkeys. |
1999 |
Vaccine |
pmid:10195786
|
Rosário M et al. |
[Profile of the resistance to macrolides and imidazoles of Helicobacter pylori in a sample of the Portuguese population]. |
1998 |
Acta Med Port |
pmid:10192979
|
Gómez-Gil E et al. |
Clarithromycin-induced acute psychoses in peptic ulcer disease. |
1999 |
Eur. J. Clin. Microbiol. Infect. Dis. |
pmid:10192720
|
Fournier S et al. |
Effect of adding clofazimine to combined clarithromycin-ethambutol therapy for Mycobacterium avium complex septicemia in AIDS patients. |
1999 |
Eur. J. Clin. Microbiol. Infect. Dis. |
pmid:10192709
|
Gimenez Garcia R et al. |
Fish tank granuloma: response to treatment with clarithromycin. |
1999 |
J Eur Acad Dermatol Venereol |
pmid:10188167
|
Craig AM et al. |
Decision analysis of Helicobacter pylori eradication therapy using omeprazole with either clarithromycin or amoxicillin. |
1996 |
Pharmacoeconomics |
pmid:10160472
|
Dempsey CL et al. |
Drug usage evaluation: clarithromycin as sequential therapy. |
1993 |
Hosp Formul |
pmid:10130382
|
Kohyama T et al. |
Fourteen-member macrolides inhibit interleukin-8 release by human eosinophils from atopic donors. |
1999 |
Antimicrob. Agents Chemother. |
pmid:10103198
|
Huang J and Hunt RH |
Clarithromycin-based triple therapies. |
1999 |
Aliment. Pharmacol. Ther. |
pmid:10102978
|
Liu WZ et al. |
Furazolidone-containing short-term triple therapies are effective in the treatment of Helicobacter pylori infection. |
1999 |
Aliment. Pharmacol. Ther. |
pmid:10102964
|
Xiao SD et al. |
High cure rate of Helicobacter pylori infection using tripotassium dicitrato bismuthate, furazolidone and clarithromycin triple therapy for 1 week. |
1999 |
Aliment. Pharmacol. Ther. |
pmid:10102963
|
Wong BC et al. |
Triple therapy for Helicobacter pylori eradication is more effective than long-term maintenance antisecretory treatment in the prevention of recurrence of duodenal ulcer: a prospective long-term follow-up study. |
1999 |
Aliment. Pharmacol. Ther. |
pmid:10102962
|
Van der Wouden EJ et al. |
The influence of metronidazole resistance on the efficacy of ranitidine bismuth citrate triple therapy regimens for Helicobacter pylori infection. |
1999 |
Aliment. Pharmacol. Ther. |
pmid:10102961
|
Zanten SJ et al. |
The DU-MACH study: eradication of Helicobacter pylori and ulcer healing in patients with acute duodenal ulcer using omeprazole based triple therapy. |
1999 |
Aliment. Pharmacol. Ther. |
pmid:10102960
|
Graham DY et al. |
Ranitidine bismuth citrate, tetracycline, clarithromycin twice-a-day triple therapy for clarithromycin susceptible Helicobacter pylori infection. |
1999 |
Aliment. Pharmacol. Ther. |
pmid:10102946
|
Tirén U et al. |
Helicobacter pylori gastritis in children: efficacy of 2 weeks of treatment with clarithromycin, amoxicillin and omeprazole. |
1999 |
Acta Paediatr. |
pmid:10102149
|
Navuluri R and Yue S |
Understanding peptic ulcer disease pharmacotherapeutics. |
1999 |
Nurse Pract |
pmid:10100245
|
Torgano G et al. |
Treatment of Helicobacter pylori and Chlamydia pneumoniae infections decreases fibrinogen plasma level in patients with ischemic heart disease. |
1999 |
Circulation |
pmid:10096930
|
Khoo KH et al. |
Altered expression profile of the surface glycopeptidolipids in drug-resistant clinical isolates of Mycobacterium avium complex. |
1999 |
J. Biol. Chem. |
pmid:10092667
|
Talley NJ et al. |
Eradication of Helicobacter pylori in functional dyspepsia: randomised double blind placebo controlled trial with 12 months' follow up. The Optimal Regimen Cures Helicobacter Induced Dyspepsia (ORCHID) Study Group. |
1999 |
BMJ |
pmid:10092259
|
Sunazuka T et al. |
Effects of erythromycin and its derivatives on interleukin-8 release by human bronchial epithelial cell line BEAS-2B cells. |
1999 |
J. Antibiot. |
pmid:10092202
|
Ong EL |
Prophylaxis against disseminated Mycobacterium avium complex in AIDS. |
1999 |
J. Infect. |
pmid:10090497
|
Ramirez J et al. |
Sparfloxacin versus clarithromycin in the treatment of community-acquired pneumonia. |
1999 |
Clin Ther |
pmid:10090428
|
GarcÃa-Romero E et al. |
[Treatment with omeprazole, clarithromycin and amoxicillin over 6 days in patients with Helicobacter pylori-infected duodenal ulcer]. |
1999 |
Gastroenterol Hepatol |
pmid:10089703
|